Information Library
Results for: White Papers - Product Development & Commercialization
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Reinventing Biopharma
February 1, 2012
The biopharmaceutical industry today is facing a multifaceted “value challenge.” -
An Integrated Approach to Biosimilar Development & Commercialization
September 29, 2011
As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents. -
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Asia
March 8, 2011
This paper examines new development models as Western companies seek to develop and register their products in Asia, while emerging Asian companies seek new capabilities to globalize products. -
2010 Executive Vision Forum Insight Report
November 18, 2010
The 2010 forum presented a venue for executives and key opinion leaders to discuss and debate the converging forces now reshaping the industry. -
Oncology Drug Development and Value-Based Medicine
November 5, 2010
This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices. -
Pharmacobiomics and Infectious Disease: Progress and Opportunities
November 2, 2010
Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits. -
From Biomarkers to Diagnostics - The Road to Success
October 18, 2010
In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity. -
Advancing Clinical Research in Alzheimer's Disease
October 18, 2010
This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010. -
Is a REMS Request from FDA More Likely for Drugs & Biologics Indicated for Pediatric Use?
October 8, 2010
Is a REMS Request From FDA More Likely For Drugs and Biologics Indicated for Pediatric Use?
